What is a Beta-2 Microglobulin (B2M) Tumor Marker Test?
A Beta-2 Microglobulin (B2M) Tumor Marker Test measures the amount of beta-2 microglobulin (B2M) in the blood and, in some cases, urine. B2M is a protein found on the surface of many cells, particularly immune system cells. Higher B2M levels can occur when there is increased activity or turnover of certain cells. Elevated levels may be associated with some blood cancers, including multiple myeloma, chronic lymphocytic leukemia (CLL), and certain lymphomas.
The test is not used alone to diagnose cancer. Instead, healthcare providers may use B2M levels alongside other laboratory tests and clinical findings to assess disease severity, estimate prognosis, monitor disease progression, and evaluate response to treatment. B2M levels can also increase due to conditions unrelated to cancer, including kidney disease, inflammation, and certain infections. Therefore, an elevated result does not necessarily mean that a person has cancer.
How is the Test Performed?
Preparation
- Fasting is usually not required.
- For CSF analysis, you may be asked to empty your bladder and bowels before the test.
- Inform your healthcare provider about any medications or supplements you are taking.
- Tell your healthcare provider if you have kidney disease or another medical condition that may affect B2M levels.
- Follow any additional instructions provided before specimen collection.
Collection
- For a blood test, a blood sample is collected from a vein in the arm using a sample needle.
- For a urine test, you will be asked to collect a urine sample for the next 24 hours.
- For a cerebrospinal fluid (CSF) analysis, your healthcare provider will perform a procedure called a
- spinal tap, also known as a lumbar puncture.
Lab Analysis
The collected sample is analyzed to measure beta-2 microglobulin (B2M) levels. The results are interpreted alongside the patient’s medical history, symptoms, kidney function, blood counts, and other cancer-related tests. In patients with certain blood cancers, B2M levels may provide information about disease activity and prognosis and may help healthcare providers monitor treatment response.
What are the Symptoms that Prompt this Test?
A Beta-2 Microglobulin (B2M) Tumor Marker Test may be recommended when a healthcare provider is evaluating certain blood cancers, monitoring an existing cancer, or assessing kidney function.
Symptoms That May Prompt This Test
Your healthcare provider may recommend a Beta-2 Microglobulin (B2M) Tumor Marker Test if you experience:
- Persistent fatigue or weakness
- Unexplained weight loss
- Fever without a known cause
- Night sweats
- Swollen lymph nodes
- Frequent infections
- Bone pain
- Unexplained anemia
- Signs of abnormal kidney function
These symptoms are not specific to elevated B2M levels and may occur with many other conditions.
Conditions That May Require This Test
A Beta-2 Microglobulin (B2M) Tumor Marker Test may also be performed if your healthcare provider suspects or is monitoring:
- Multiple myeloma
- Chronic lymphocytic leukemia (CLL)
- Lymphoma
- Other blood cancers
- Kidney disease
- Certain inflammatory conditions
- Some viral infections
The test may also be used to monitor disease progression or assess how well a patient is responding to cancer treatment.
What are Normal Ranges for This Test?
The beta-2 microglobulin (B2M) tumor marker normal range depends on the type of specimen tested, the laboratory, and the testing method.
For blood testing, a typical reference range may be approximately:
0.7–3.0mg/L
However, reference ranges can differ between laboratories.
For urine testing, the expected level is generally low because healthy kidneys normally prevent significant amounts of B2M from passing into urine.
“The reference ranges vary depending on the laboratory and the methodology used. Individuals must consult their healthcare provider for correct interpretation of the results.”
What Happens if Test Results Show Abnormal Levels?
Abnormal Beta-2 Microglobulin (B2M) Tumor Marker Test results may be associated with cancer, kidney problems, or other medical conditions.
High B2M Levels
Elevated B2M levels may be associated with:
- Multiple myeloma
- Chronic lymphocytic leukemia (CLL)
- Lymphoma
- Other blood cancers
- Kidney disease
- Chronic inflammation
- Certain viral infections
In people with certain blood cancers, higher B2M levels may be associated with a greater amount of disease or a less favorable prognosis. However, B2M levels alone cannot diagnose cancer or determine the exact stage of disease.
Kidney problems can also cause B2M to build up in the blood because the kidneys are less able to remove it from the body.
Low B2M Levels
Low B2M levels are generally not considered clinically significant and usually do not indicate a specific disease.
Abnormal Urine B2M Levels
Increased B2M in urine may indicate that the kidney’s tubules are not functioning properly. This can occur with certain types of kidney damage or conditions affecting tubular function.
Depending on the results, your healthcare provider may recommend additional investigations such as:
- Complete Blood Count (CBC)
- Serum Protein Electrophoresis (SPEP)
- Immunofixation Electrophoresis
- Free Light Chain Assay
- Kidney Function Tests
- Creatinine Test
- Bone Marrow Biopsy
- Imaging tests
Need a Beta-2 Microglobulin (B2M) Tumor Marker Test? Book your appointment today for reliable laboratory testing and professional clinical support.
